MDS 2021 | Neurological manifestations of COVID-19: what do we know?

Neurological manifestations of COVID-19 have been noted since the earliest reports of SARS-CoV-2 infection and since then, a growing volume of literature has been shared looking into the prevalence, spectrum, underlying pathophysiology, and long-term implications of neurological symptoms. Hadi Manji, MA, MB Bchir, MD, FRCP, National Hospital for Neurology, UCLH Foundation Trust, London, UK, discusses what we know about the impacts of this virus on the nervous system. Encephalopathy, encephalitis, acute disseminated encephalomyelitis, and stroke have all been associated with COVID-19. This interview took place during the 2021 International Congress of Parkinson’s Disease and Movement Disorders.